Skip to content
★ Sign in to follow
AM

Allgens Medical Technology Co., Ltd. Stock: price and insider trades · China

奥精医疗

CN·Mcap CN¥2.4BHealth Care

No insider purchase over the last 90 days. The latest, by 王玲, was filed 29 Apr 2025.

Allgens Medical Technology Co., Ltd.: what insiders have been doing

Allgens Medical Technology Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Between 5 November 2025 and 5 November 2026, 4 insiders published 11 filings.

Only sales appear on the open market, 11 sales in all totalling €383k, filed by 4 insiders. Biggest ticket of the year: €130k, sold by 仇志烨 and made public on 22 December 2025.

The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

Across the 517 companies tracked on its exchange, the median is 2 filings; at 11 filings, this issuer sits above that mark. The full history, which starts in 2025, counts 1 purchase against 11 sales.

In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Insider Decl.
12
Thresholds
n/a
Buy Volume
€140,188
1 ops. · all time
Sell Volume
€382,608
11 ops. · all time

Who traded when

BuySale
宋天喜5 sales
王玲1 buy3 sales
仇志烨2 sales
田国峰1 sale

Since the insiders bought

  • Filed 29 Apr 2025 · 558 days ago · €140k
    +29.6%
    Entry CN¥15.90 · Close at T+365 CN¥20.60

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 14,990 of 26,911 companies
48.2
score / 100
Value
38
Quality
58
FCF yld0.4%
Earn yld0.6%
EV/EBITDA·
ROE0.4%
Gross mgn69%
Net mgn6.2%
Debt/EBITDA1.3x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥17.70
Analyst consensus
·
Income statement
RevenueCN¥223.7M
Gross profitCN¥153.6M69% margin
EBITDACN¥36.4M16% margin
Net incomeCN¥13.8M3.8% margin
Valuation
PER (trailing)295.0x
P/Book1.7x
Beta0.60
Balance sheet & cash
Market capCN¥2.4B
Total debtCN¥47.9M
Free Cash FlowCN¥10.6M
Debt / Equity2%
Profitability & ownership
ROE0.4%
ROA-0.2%
% insiders31.0%
% institutions4.5%
Last declaration on 31 December 2025
Declarations12 total
  • ▼
    董事Executives
    203,200 CNY27SSE
    10,000 shares19.7% of flowA股XSHGSSE:273000000077323070
  • ▼
    高级管理人员Executives
    101,350 CNY30SSE
    5,000 shares7.5% of flowA股XSHGSSE:273000000077323000
  • ▼
    高级管理人员Executives
    51,650 CNY29SSE
    2,500 shares3.8% of flowA股XSHGSSE:273000000073774560
  • ▼
    董事Executives
    323,850 CNY28SSE
    15,000 shares31.3% of flowA股XSHGSSE:273000000052853500
  • ▼
    董事Executives
    1M CNY33SSE
    50,000 shares83.7% of flowA股XSHGSSE:273000000052853570
  • ▼
    董事Executives
    100,925 CNY26SSE
    5,000 shares9.7% of flowA股XSHGSSE:273000000042618270
  • ▼
    董事Executives
    650,943 CNY33SSE
    32,500 shares100.0% of flowA股XSHGSSE:273000000025875800
  • ▼
    董事Executives
    205,650 CNY24SSE
    10,000 shares20.0% of flowA股XSHGSSE:273000000013135360
  • ▼
    董事Executives
    208,000 CNY24SSE
    10,000 shares16.3% of flowA股XSHGSSE:273000000013135500
  • ▼
    高级管理人员Executives
    40,060 CNY23SSE
    2,000 shares3.0% of flowA股XSHGSSE:273000000008960200
  • ▼
    董事Executives
    198,850 CNY21SSE
    10,000 shares19.3% of flowA股XSHGSSE:273000000008960160
  • ▲
    高级管理人员Executives
    1M CNY19SSE
    115,000 shares85.7% of flowA股XSHGSSE:173000008891591500
    Canonical exit: 28 Jul 2025 (T+90)

12 of 12 declarations

About Allgens Medical Technology Co., Ltd.

奥精医疗 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the development and commercialization of innovative medical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations